$121 Million is the total value of HighVista Strategies LLC's 100 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 500.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WLTW | Buy | WILLIS TOWERS WATSON PLC LTD | $8,086,000 | +132.2% | 41,056 | +100.3% | 6.70% | +107.6% |
| TECD | Buy | TECH DATA CORP | $7,912,000 | +107.8% | 54,600 | +87.6% | 6.55% | +85.8% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $7,765,000 | +12.1% | 36,000 | +1.1% | 6.43% | +0.3% |
| AMTD | Buy | TD AMERITRADE HLDG CORP | $6,644,000 | +20.1% | 182,630 | +14.4% | 5.50% | +7.4% |
| TIF | Buy | TIFFANY & CO NEW | $6,230,000 | +93.2% | 51,092 | +105.2% | 5.16% | +72.7% |
| CZR | New | CAESARS ENTMT CORP | $4,154,000 | – | 342,418 | +100.0% | 3.44% | – |
| WMGI | New | WRIGHT MED GROUP N V | $2,911,000 | – | 97,960 | +100.0% | 2.41% | – |
| LOGM | New | LOGMEIN INC | $2,891,000 | – | 34,109 | +100.0% | 2.39% | – |
| INDA | Buy | ISHARES TRmsci india etf | $1,483,000 | +20.9% | 51,100 | +0.4% | 1.23% | +8.1% |
| AXSM | New | AXSOME THERAPEUTICS INC | $571,000 | – | 6,941 | +100.0% | 0.47% | – |
| CCXI | New | CHEMOCENTRYX INC | $562,000 | – | 9,769 | +100.0% | 0.46% | – |
| PRNB | New | PRINCIPIA BIOPHARMA INC | $548,000 | – | 9,165 | +100.0% | 0.45% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $547,000 | – | 26,198 | +100.0% | 0.45% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $538,000 | – | 21,201 | +100.0% | 0.44% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $524,000 | – | 25,024 | +100.0% | 0.43% | – |
| TGTX | New | TG THERAPEUTICS INC | $512,000 | – | 26,269 | +100.0% | 0.42% | – |
| EIDX | New | EIDOS THERAPEUTICS INC | $505,000 | – | 10,596 | +100.0% | 0.42% | – |
| ARVN | New | ARVINAS INC | $485,000 | – | 14,467 | +100.0% | 0.40% | – |
| KURA | New | KURA ONCOLOGY INC | $485,000 | – | 29,741 | +100.0% | 0.40% | – |
| KOD | New | KODIAK SCIENCES INC | $479,000 | – | 8,839 | +100.0% | 0.40% | – |
| NLTX | New | NEOLEUKIN THERAPEUTICS INC | $474,000 | – | 28,552 | +100.0% | 0.39% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $461,000 | – | 7,717 | +100.0% | 0.38% | – |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $450,000 | – | 25,701 | +100.0% | 0.37% | – |
| New | TRILLIUM THERAPEUTICS INC | $449,000 | – | 55,556 | +100.0% | 0.37% | – | |
| IGMS | New | IGM BIOSCIENCES INC | $449,000 | – | 6,146 | +100.0% | 0.37% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $447,000 | – | 14,888 | +100.0% | 0.37% | – |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $447,000 | – | 10,649 | +100.0% | 0.37% | – |
| TCDA | New | TRICIDA INC | $446,000 | – | 16,235 | +100.0% | 0.37% | – |
| INSM | New | INSMED INC | $438,000 | – | 15,906 | +100.0% | 0.36% | – |
| KDMN | New | KADMON HLDGS INC | $433,000 | – | 84,612 | +100.0% | 0.36% | – |
| SGEN | New | SEATTLE GENETICS INC | $433,000 | – | 2,549 | +100.0% | 0.36% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $434,000 | – | 9,693 | +100.0% | 0.36% | – |
| CDXS | New | CODEXIS INC | $433,000 | – | 38,009 | +100.0% | 0.36% | – |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $428,000 | – | 2,893 | +100.0% | 0.35% | – |
| FATE | New | FATE THERAPEUTICS INC | $428,000 | – | 12,463 | +100.0% | 0.35% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $426,000 | – | 8,794 | +100.0% | 0.35% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $425,000 | – | 15,481 | +100.0% | 0.35% | – |
| VSTM | New | VERASTEM INC | $425,000 | – | 247,059 | +100.0% | 0.35% | – |
| ALEC | New | ALECTOR INC | $424,000 | – | 17,352 | +100.0% | 0.35% | – |
| STOK | New | STOKE THERAPEUTICS INC | $423,000 | – | 17,734 | +100.0% | 0.35% | – |
| ARGX | New | ARGENX SEsponsored adr | $422,000 | – | 1,872 | +100.0% | 0.35% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $421,000 | – | 5,396 | +100.0% | 0.35% | – |
| KALA | New | KALA PHARMACEUTICALS INC | $420,000 | – | 39,943 | +100.0% | 0.35% | – |
| ZYME | New | ZYMEWORKS INC | $418,000 | – | 11,593 | +100.0% | 0.35% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $417,000 | – | 3,384 | +100.0% | 0.34% | – |
| PTCT | New | PTC THERAPEUTICS INC | $416,000 | – | 8,198 | +100.0% | 0.34% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $415,000 | – | 2,805 | +100.0% | 0.34% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $415,000 | – | 51,408 | +100.0% | 0.34% | – |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $415,000 | – | 18,609 | +100.0% | 0.34% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $412,000 | – | 2,570 | +100.0% | 0.34% | – |
| ZGNX | New | ZOGENIX INC | $411,000 | – | 15,217 | +100.0% | 0.34% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $408,000 | – | 3,577 | +100.0% | 0.34% | – |
| MYOK | New | MYOKARDIA INC | $408,000 | – | 4,224 | +100.0% | 0.34% | – |
| ALLK | New | ALLAKOS INC | $405,000 | – | 5,635 | +100.0% | 0.34% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $405,000 | – | 26,863 | +100.0% | 0.34% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $395,000 | – | 6,261 | +100.0% | 0.33% | – |
| MBT | Buy | MOBILE TELESYSTEMS PJSCsponsored adr | $393,000 | +112.4% | 42,800 | +75.4% | 0.32% | +90.1% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $375,000 | – | 11,266 | +100.0% | 0.31% | – |
| BCEL | New | ATRECA INC | $326,000 | – | 15,330 | +100.0% | 0.27% | – |
| CHKP | New | CHECK POINT SOFTWARE TECH LTord | $301,000 | – | 2,800 | +100.0% | 0.25% | – |
| SCCO | New | SOUTHERN COPPER CORP | $262,000 | – | 6,600 | +100.0% | 0.22% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $254,000 | – | 20,239 | +100.0% | 0.21% | – |
| QNST | New | QUINSTREET INC | $130,000 | – | 12,400 | +100.0% | 0.11% | – |
| TPCO | New | TRIBUNE PUBG CO NEW | $112,000 | – | 11,200 | +100.0% | 0.09% | – |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $104,000 | +103.9% | 15,000 | +40.2% | 0.09% | +83.0% |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $83,000 | +93.0% | 26,800 | +43.3% | 0.07% | +72.5% |
| OSMT | New | OSMOTICA PHARMACEUTICALS PLC | $79,000 | – | 11,800 | +100.0% | 0.06% | – |
| WSR | New | WHITESTONE REIT | $75,000 | – | 10,300 | +100.0% | 0.06% | – |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $74,000 | +85.0% | 40,200 | +56.4% | 0.06% | +64.9% |
| RYI | New | RYERSON HLDG CORP | $70,000 | – | 12,400 | +100.0% | 0.06% | – |
| ARAY | Buy | ACCURAY INC | $57,000 | +103.6% | 28,300 | +89.9% | 0.05% | +80.8% |
| EPM | Buy | EVOLUTION PETROLEUM CORP | $55,000 | +66.7% | 19,800 | +54.7% | 0.05% | +48.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 29 | Q2 2023 | 2.9% |
| VANGUARD INDEX FDS | 24 | Q4 2019 | 26.4% |
| APPLE INC | 24 | Q4 2019 | 2.0% |
| ISHARES TR | 22 | Q3 2018 | 7.9% |
| MICROSOFT CORP | 21 | Q3 2023 | 2.0% |
| VISA INC | 20 | Q3 2023 | 5.8% |
| INVESCO DB COMMDY INDX TRCK | 20 | Q3 2023 | 16.6% |
| VERIZON COMMUNICATIONS INC | 20 | Q4 2019 | 0.4% |
| ALIBABA GROUP HLDG LTD | 19 | Q3 2023 | 7.7% |
| AMAZON COM INC | 19 | Q3 2023 | 2.9% |
View HighVista Strategies LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STG Group, Inc.Sold out | February 16, 2016 | 0 | 0.0% |
| SAExploration Holdings, Inc. | February 12, 2014 | 25,000 | 0.2% |
| Trio Merger Corp. | February 14, 2013 | 690,000 | 8.8% |
View HighVista Strategies LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View HighVista Strategies LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.